FDA reverses course on controversial budget cut

A plan to cut the budget for the FDA's Office of Women's Health by 25 percent has been scrapped after a number of activist groups applied pressure on FDA Commissioner Andrew Von Eschenbach. The agency announced that the unit's funding would remain $4 million for fiscal 2007. That wasn't enough to satisfy critics of the recent budget-cutting move, but reversing course did trigger a few celebrations among the agency's harshest critics.

- read the Washington Post report

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.